Livtencity Tablet, Coated
Product Images NDC 64764-800

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Livtencity (NDC 64764-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Maribavir 01)

Chemical structure of maribavir depicting its chlorinated aromatic ring and sugar moiety, consistent with the active ingredient in Livtencity 200 mg coated tablets by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Principal Display Panel (200 mg Bottle Carton)

Packaging label for Livtencity 200 mg coated tablets containing maribavir. The label includes the proprietary name Livtencity and generic name maribavir, with dosing information stating 400 mg (two 200 mg tablets) twice daily. The package contains 28 tablets for oral use, distributed by Takeda Pharmaceuticals America, Inc., Lexington, MA. The label features the Takeda logo and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.